FINWIRES · TerminalLIVE
FINWIRES

HUTCHMED Licenses Cancer Drug to GSK for Up to $1.30 Billion; Shares Up 12%

By

HUTCHMED (HKG:0013) agreed to grant a GSK subsidiary worldwide rights, excluding Mainland China, Hong Kong, Macau, and Taiwan, to develop and commercialize its experimental cancer drug HMPL-A830 for up to $1.30 billion.

The deal includes a $110 million upfront payment, potential development, regulatory and commercial milestones of up to $1.19 billion, and royalties on net sales, according to a Thursday Hong Kong exchange filing.

HUTCHMED will lead the initial global Phase I program, expected to start in the second half of 2026, while GSK will take over subsequent development and commercialization outside the retained territories. The initial program will focus on colorectal, pancreatic and lung cancers.

Shares of the company rose 12% in recent trade.

Related Articles

Asia

Market Chatter: Komatsu to Raise Construction Equipment Supply to North America on Greater Demand for Data Centers

Komatsu (TYO:6301) looks to increase product supply to North America to meet demand for data center construction amid the AI boon, Nikkei Asia reported Wednesday, citing CFO Hiroshi Hosotani.The company's sales of construction equipment in the region grew 29% year over year, Hosotani said in an interview with the news outlet.The data center market could further grow for another five years, given that building data centers can continue for a long time, the executive said in the interview.The company will also focus on improving inventory levels through optimal production planning to anchor free cash flow, the report cited Hosotani as saying.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

TYO:6301
Asia

Xingye Silver & Tin Mining's Unit Resumes Operations After Accident; Shares Up 4%

Inner Mongolia Xingye Silver & Tin Mining's (SHE:000426) unit, Xiwuzhumuqin Banner Yinman Mining, resumed operations after being shut down due to an accident that brought one casualty, according to a Shenzhen bourse filing on Thursday.Yinman Mining's production at its mining area and its mineral processing tailings system were temporarily suspended following a work accident during production at the mine's underground Third Mining Area on July 26.The metals miner's shares jumped 4% during the morning trade.

SHE:000426
Asia

Kafelaku Coffee Upsizes Private Placement to HK$11.6 Million

Kafelaku Coffee Holding (HKG:1869) has revised the terms for its private placement offering to raise HK$11.6 million, up from HK$11 million, according to a Wednesday bourse filing.The specialty coffee chain said it will now offer 282.1 million shares at HK$0.041 apiece, up from HK$0.039. The new offer price represents an 18% discount to the stock's last closing price.Kafelaku also extended the offering closing date to Sept. 23 from Sept. 2.Shares of the company are down 4% in open market trading on the HKEX.

HKG:1869